JIR
RDY icon

James Investment Research’s Dr. Reddy's Laboratories RDY Stock Holding History

James Investment Research’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,805
Closed -$29K – 632
2022
Q4 		$29K Buy
+2,805
New +$30.3K ﹤0.01% 409

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

James Investment Research's RDY Position: Q1 2023 in Review

James Investment Research sold out of Dr. Reddy's Laboratories (RDY) in Q1 2023, closing a stake of 2,805 shares — an estimated $29K sold.

James Investment Research first reported a position in RDY in Q4 2022 and held it in 1 quarter. The position peaked at $29K in Q4 2022. 189 funds tracked by Wall St. Rank hold RDY as of Q1 2023.

  • James Investment Research reported no remaining Dr. Reddy's Laboratories position as of Q1 2023 after selling out during the quarter.
  • James Investment Research sold 2,805 Dr. Reddy's Laboratories shares in Q1 2023, an estimated $29K.
  • James Investment Research first reported a position in Dr. Reddy's Laboratories in Q4 2022 and held it in 1 quarter.
  • James Investment Research's Dr. Reddy's Laboratories position peaked at $29K in Q4 2022.
  • 189 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2023.

Based on James Investment Research's 13F filing for Q1 2023, filed 26 Apr 2023.